SCHEMBL25539803

SCHEMBL25539803

CC1(C)c2ccccc2-c2cccc(-c3cc(-c4ccccc4)nc(-c4ccc(-c5cccc6c5C(C)(C)c5c-6ccc6ccccc56)c5ccccc45)n3)c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539116 0.94 MAPT (0.32) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25538905 0.93 ENPP3 (0.34) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25539804 0.92 PDK2 (0.36) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25537282 0.92 MEN1 (0.36) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25534328 0.92 MEN1 (0.38) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25534540 0.92 MEN1 (0.38) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25539768 0.92 HPGD (0.39) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25540332 0.92 HPGD (0.39) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25538413 0.91 MEN1 (0.41) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL25540340 0.91 MEN1 (0.41) MAPTKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MAPT 1595/4885KDM4E 1565/4885ALDH1A1 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.